Randomized Phase II Study of Bortezomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Multiple Myeloma.
Condition: Multiple Myeloma Intervention: Drug: Renalidomide, Velcade, Dexamethasone Sponsor: Samsung Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials